Pretreatment Neutrophil/Lymphocyte Ratio as a Prognostic Aid in Colorectal Cancer |
Ozdemir, Yavuz
(Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital)
Akin, Mehmet Levhi (Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital) Sucullu, Ilker (Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital) Balta, Ahmet Ziya (Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital) Yucel, Ergun (Department of Surgery, Gulhane Military Medical Academy, Haydarpasa Teaching Hospital) |
1 | Malietzis G, Giacometti M, Askari A, et al (2013). A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg.(Epub ahead of print) |
2 | Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005). Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol, 91, 181-4. DOI ScienceOn |
3 | Zahorec R (2001). Ratio of neutrophil to lymphocyte counts-- rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102, 5-14. |
4 | Roxburgh CS, McMillan DC (2010). Role of systemic inflammatory response in predicting survival in patients with primer operable cancer. Future Oncol, 6, 149-63 DOI ScienceOn |
5 | Li MX, Liu XM, Zhang XF, et al (2013). Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer, (Epub ahead of print) |
6 | Shin R, Jeong SY, Yoo HY, et al (2012). Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer. Dis Colon Rectum, 55, 1220-8. DOI ScienceOn |
7 | Ownby HE, Roi LD, Isenberg RR, Brennan MJ (1983). Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer, 52, 126-30. |
8 | Strieter RM, Burdick MD, Mestas J, et al (2006). Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer. 42, 768-78 DOI ScienceOn |
9 | Suzuki O, Sekishita Y, Shiono T, et al (2006). Number of lymph node metastases is better predictor of prognosis than level of lymph node metastasis in patients with node-positive colon cancer. J Am Coll Surg, 202,732-6. DOI ScienceOn |
10 | Turkish Public Health Foundation, Cancer statistics 2009 ( http://www.kanser.gov.tr/haberler/921-2009-turkiye-kanseristatistikleri- yayimlandi.html) |
11 | Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42. DOI ScienceOn |
12 | Waldner M, Schimanski CC, Neurath MF (2006). Colon cancer and the immune system: The role of tumor invading T cells. World J Gastroenterol, 12, 7233-38 |
13 | Jung MR, Park YK, Jeong O, et al (2011). Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stagegastric cancer. J Surg Oncol, 104, 504-10. DOI ScienceOn |
14 | Halazun KJ, Aldoori A, Malik HZ, et al (2008). Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol, 34, 55-60. DOI ScienceOn |
15 | He W, Yin C, Guo G, et al (2013). Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol, 30, 439. DOI ScienceOn |
16 | Kishi Y, Kopetz S, Chun YS, et al (2009). Blood neutrophil-tolymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol, 16, 614-22. DOI ScienceOn |
17 | Hung HY, Chen JS, Yeh, et al (2011). Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis, 26, 1059-65. DOI |
18 | Kao SC, Pavlakis N, Harvie R, et al (2010). High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res, 16, 5805-13. DOI |
19 | Kaya V, Yildirim M, Demirpence O, Yildiz M, Yalcin AY (2013). Prognostic significance of basic laboratory methods in nonsmall- cell-lung cancer. Asian Pac J Cancer Prev, 14, 5473-6. DOI ScienceOn |
20 | Leitch EF, Chakrabarti M, Crozier JE, et al (2007). Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer, 97, 1266-70. DOI ScienceOn |
21 | Aliustaoglu M, Bilici A, Seker M, et al (2010). The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer. Hepatogastroenterology. 57, 640-5. |
22 | American Cancer Society (2013). Cancer Facts and Figures 2013. Atlanta, Ga: American Cancer Society, Also available online. Last accessed January 22, 2013. |
23 | Azab B, Bhatt VR, Phookan J, et al (2012). Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol, 19, 217-24. DOI ScienceOn |
24 | De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, et al (2006). Prognostic value of the lymph node ratio in node positive colon cancer. Gut, 55, 1681 DOI ScienceOn |
25 | Cedres S, Torrejon D, Martinez A, et al (2012). Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol, 14, 864-9. DOI ScienceOn |
26 | Chiang SF, Hung HY, Tang R, et al (20129. Can neutrophil-tolymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis, 27, 1347-57. DOI |
27 | Cho H, Hur HW, Kim SW, et al (2009). Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother, 58, 15-23. DOI ScienceOn |
28 | Ding PR, An X, Zhang RX, et al (2010). Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis, 25, 1427-33. DOI |
29 | Absenger G, Szkandera J, Stotz M, et al (2013) Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer. Anticancer Res, 33, 4591-4. |
30 | Bolocan A, Ion D, Ciocan DN, Paduraru DN (2012). Prognostic and predictive factors in colorectal cancer. Chirurgia (Bucur). 107, 555-63. |
![]() |